Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites

Parasitology

Volumn 139, Issue 7, 2012, Pages 934-944

  Debache, Karim ^a   Hemphill, Andrew ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

cultured fibroblasts; miltefosine; Neospora caninum; proliferation; tachyzoites

Indexed keywords

MILTEFOSINE; PLACEBO;

ARTICLE; BAGG ALBINO MOUSE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MALE; MOUSE; NEOSPORA CANINUM; NEOSPOROSIS; NONHUMAN; PREPUCE; PRIORITY JOURNAL; TACHYZOITE; TRANSMISSION ELECTRON MICROSCOPY; WEIGHT REDUCTION;

ANIMALS; ANTIPROTOZOAL AGENTS; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COCCIDIOSIS; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; HUMANS; MICE; MICE, INBRED BALB C; NEOSPORA; PARASITIC SENSITIVITY TESTS; PHOSPHORYLCHOLINE; TREATMENT OUTCOME; VERO CELLS;

MUS; NEOSPORA CANINUM;

EID: 84861917562     PISSN: 00311820     EISSN: 14698161     Source Type: Journal    
DOI: 10.1017/S0031182012000066     Document Type: Article

References (49)

1. Alaeddine, F., Keller, N., Leepin, A. and Hemphill, A. (2005). Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. Journal of Parasitology 91, 657-665. (Pubitemid 40993458)
2. Barratt, G., Saint-Pierre-Chazalet, M. and Loiseau, P. M. (2009). Cellular transport and lipid interactions of miltefosine. Current Drug Metabolism 10, 247-255.
3. Bhattacharya, S. K., Sinha, P. K., Sundar, S., Thakur, C. P., Jha, T. K., Pandey, K., Das, V. R., Kumar, N., Lal, C., Verma, N., Singh, V. P., Ranjan, A., Verma, R. B., Anders, G., Sinderman, H. and Ganguly, N. K. (2007). Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis. Journal of Infectious Diseases 196, 591-598. (Pubitemid 47206107)
4. Cannas, A., Naguleswaran, A., Müller, N., Gottstein, B., Eperon, S. and Hemphill, A. (2003a). Vaccination of mice against experimental N. caninum infection using NcSAG1-and NcSRS2-based recombinant antigens and DNA-vaccines. Parasitology 126, 303-312. (Pubitemid 36520944)
5. Cannas, A., Naguleswaran, A., Müller, N., Gottstein, B. and Hemphill, A. (2003b). Reduced cerebral infection of Neospora caninuminfected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. Journal of Parasitology 89, 44-50. (Pubitemid 36278646)
6. Choubey, V., Maity, P., Guha, M., Kumar, S., Srivastava, K., Puri, S. K. and Bandyopadhyay, U. (2007). Inhibition of Plasmodium falciparum choline kinase by hexadecyltrimethylammonium bromide: a possible antimalarial mechanism. Antimicrobial Agents and Chemotherapy 51, 696-706. (Pubitemid 46185292)
7. Croft, S. L., Snowdon, D. and Yardley, V. (1996). The activities of four anticancer alkyllysophospholipids against Leishmania donovani, Trypanosoma cruzi and Trypanosoma brucei. Antimicrobial Agents and Chemotherapy 6, 1041-7. (Pubitemid 27073283)
8. Croft, S. L., Engel, J. (2006). Miltefosine-discovery of the antileishmanial activity of phospholipid derivatives. Transactions of the Royal Society of Tropical Medicine and Hygiene 100, S4-S8. (Pubitemid 44490168)
9. Darius, A. K., Mehlhorn, H. and Heydorn, A. O. (2004). Effects of toltrazuril and ponazuril on the fine structure and multiplication of tachyzoites of the NC-1 strain of Neospora caninum (a synonym of Hammondia heydorni) in cell cultures. Parasitology Research 92, 453-458. (Pubitemid 38658338)
10. Debache, K., Alaeddine, F., Guionaud, C., Monney, T., Müller, J., Strohbusch, M., Leib, S. L., Grandgirard, D. and Hemphill, A. (2009). Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. International Journal for Parasitology 39, 1373-1384.
11. Debache, K., Guionaud, C., Kropf, C., Boykin, D. and Hemphill, A. (2011). Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide. Experimental Parasitology 129, 95-100.
12. Dubey, J. P., Hattel, A. L., Lindsay, D. S. and Topper, M. J. (1988). Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. Journal of the American Veterinary Medical Association 193, 1259-1263.
13. Dubey, J.P. and Schares, G. (2011). Neosporosis in animals the last five years. Veterinary Parasitology 180, 90-108.
14. Dubey, J. P., Schares, G. and Ortega-Mora, L. M. (2007). Epidemiology and control of neosporosis and Neospora caninum. Clinical Microbiology. Microbiology Reviews 20, 323-367. (Pubitemid 46709307)
15. Escobar, P., Yardely, V., and Croft, S. L. (2001). Activities of hexadecylphosphocholine (Miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrobial Agents and Chemotherapy 45, 1872-1875. (Pubitemid 32466363)
16. Esposito, M., Moores, S., Naguleswaran, A., Mueller, J. and Hemphill, A. (2007a). Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro-and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs. International Journal for Parasitology 37, 1143-1152. (Pubitemid 47042028)
17. Esposito, M., Muller, N. and Hemphill, A. (2007b). Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. International Journal for Parasitology 37, 183-190. (Pubitemid 46074023)
18. Esposito, M., Stettler, R., Moores, S. L., Pidathala, C., Muller, N., Stachulski, A., Berry, N. G., Rossignol, J. F. and Hemphill, A. (2005). In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group. Antimicrobial Agents and Chemotherapy 49, 3715-3723. (Pubitemid 41233023)
19. Gottstein, B., Eperon, S., Dai, W. J., Cannas, A., Hemphill, A. and Greif, G. (2001). Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice. Parasitology Research 87, 43-48. (Pubitemid 32710167)
20. Haerdi, C., Haessig, M., Sager, H., Greif, G., Staubli, D. and Gottstein, B. (2006). Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril. Parasitology Research 99, 534-540. (Pubitemid 44337939)
21. Häsler, B., Regula, G., Stärk, K. D., Sager, H., Gottstein, B. and Reist, M. (2006b). Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland. Preventive Veterinary Medicine 77, 230-253. (Pubitemid 44708366)
22. Häsler, B., Stärk, K. D., Sager, H., Gottstein, B. and Reist, M. (2006a). Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle. Preventive Veterinary Medicine 77, 254-283. (Pubitemid 44708367)
23. Hemphill, A. (1996). Subcellular localization and functional characterization of Nc-p43, a major Neospora caninum tachyzoite surface protein. Infection and Immunity 64, 4279-4287. (Pubitemid 26318154)
24. Kim, J. T., Park, J. Y., Seo, H. S., Oh, H. G., Noh, J.W., Kim, J. H., Kim, D. Y. and Youn, H. J. (2002). In vitro antiprotozoal effects of artemisinin on Neospora caninum. Veterinary Parasitology 103, 53-63.
25. Konstantinov, S. M., Kaminsky, R., Brun, R., Berger, M. R. and Zillmann, U. (1997). Efficacy of anticancer alkylphosphocholines in Trypanosoma brucei subspecies. Acta Tropica 64, 145-154. (Pubitemid 27191478)
26. Kritzner, S., Sager, H., Blum, J., Krebber, R., Greif, G. and Gottstein, B. (2002). An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum. Annals of Clinical Microbiology and Antimicrobials 1, 4-10.
27. Kwon, H. J., Kim, J. H., Kim, M., Lee, J. K., Hwang, W. S. and Kim, D. Y. (2003). Anti-parasitic activity of depudecin on Neospora caninum via the inhibition of histone deacetylase. Veterinary Parasitology 112, 269-276. (Pubitemid 36293668)
28. Leepin, A., Studli, A., Brun, R., Stephens, C. E., Boykin, D.W. and Hemphill, A. (2008). Host cells participate in the in vitro effects of novel diamidine analogues against tachyzoites of the intracellular apicomplexan parasites Neospora caninum and Toxoplasma gondii. Antimicrobial Agents and Chemotherapy 52, 1999-2008. (Pubitemid 351758535)
29. Leonard, R., Hardy, J., van Tienhoven, G., Houston, S., Simmonds, P., David, M. and Mansi, J. (2001). Randomized, doubleblind, placebo-controlled, multicenter trial of 6% miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. Journal of Clinical Oncology 19, 4150-4159. (Pubitemid 33049533)
30. Lindsay, D. S. and Dubey, J. P. (1989). Evaluation of anti-coccidial drugs' inhibition of Neospora caninum development in cell cultures. Journal of Parasitology 75, 990-992. (Pubitemid 20099179)
31. Lindsay, D. S. and Dubey, J. P. (1990). Effects of sulfadiazine and amprolium on Neospora caninum (Protozoa: Apicomplexa) infections in mice. Journal of Parasitology 76, 177-179. (Pubitemid 20156033)
32. Lindsay, D. S., Rippey, N. S., Cole, R. A., Parsons, L. C., Dubey, J. P., Tidwell, R. R. and Blagburn, B. L. (1994). Examination of the activities of 43 chemotherapeutic agents against Neospora caninum tachyzoites in cultured cells. American Journal of Veterinary Research 55, 976-981. (Pubitemid 24239863)
33. Lux, H., Heise, N., Klenner, T., Hart, D. and Opperdoes, F. R. (2000). Ether-lipid (alkyl-phospholipid) metabolism and the mechanism of action of ether-lipid analogues in Leishmania. Molecular and Biochemical Parasitology 111, 1-14.
34. Monney, T., Debache, K. and Hemphill, A. (2011). Vaccines against a major cause of abortion in cattle, Neospora caninum infection. Animals 1, 306-325.
35. Müller, N., Vonlaufen, N., Gianinazzi, C., Leib, S. L. and Hemphill, A. (2002). Application of real time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous tissue. Journal of Clinical Microbiology 40, 252-255. (Pubitemid 34027632)
36. Oliveira, L. F., Schubach, A. O., Martins, M. M., Passos, S. L., Oliveira, R. V., Marzochi, M. C. and Andrade, C. A. (2011). Systematic review of the adverse effects of cutaneous Leishmaniasis treatment in the New World. Acta Tropica 118, 87-96.
37. Paris, C., Loiseau, P. M., Bories, C. and Bréard, J. (2004). Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrobial Agents and Chemotherapy 48, 852-859. (Pubitemid 38280335)
38. Perez-Victoria, F. J., Sanchez-Canete, M. P., Seifert, K., Croft, S. L., Sundar, S., Castanys, S. and Gamarro, F. (2006). Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use. Drug Resistance Updates 9, 26-39. (Pubitemid 43928805)
39. Pessi, G., Kociubinski, G. and Mamoun, C. B. (2004). A pathway for phosphatidylcholine biosynthesis in Plasmodium falciparum involving phosphoethanolamine methylation. Proceedings of the National Academy of Sciences, USA 101, 6206-6211. (Pubitemid 38520552)
40. Rakotomanga, M., Blanc, S., Gaudin, K., Chaminade, P. and Loiseau, P. M. (2007). Miltefosine affects lipid metabolism in Leishmania donovani promastigotes. Antimicrobial Agents and Chemotherapy 51,1425-1430. (Pubitemid 46586825)
41. Schuster, F. L., Guglielmo, B. J. and Visvesvara, G. S. (2006). In-vitro activity of miltefosine and voriconazole on clinical isolates of free-living amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri.Journal of Eukaryotic Microbiology 53, 121-126. (Pubitemid 43357017)
42. Seifert, K., Duchêne, M., Wernsdorfer, W. H., Kollaritsch, H., Scheiner, O., Wiedermann, G., Hottkowitz, T. and Eibl, H. (2001). Effects of miltefosine and other alkylphosphocholines on human intestinal parasite Entamoeba histolytica. Antimicrobial Agents and Chemotherapy 45, 1505-1510. (Pubitemid 32374125)
43. Shahiduzzaman, M., Dyachenko, V., Obwaller, A., Unglaube, S. and Daugschies, A. (2009). Combination of cell culture and quantitative PCR for screening of drugs against Cryptosporidium parvum. Veterinary Parasitology 162, 271-277.
44. Strohbusch, M., Müller, N., Hemphill, A., Krebber, R., Greif, G. and Gottstein, B. (2009). Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice. Parasitology Research 104, 1335-1343.
45. Unger, C., Damenz, W., Fleer, E. A., Kim, D. J., Breiser, A., Hilgard, P., Engel, J., Nagel, G. and Eibl, H. (1989). Hexadecylphosphocholine, a new ether lipid analogue. Studies on the antineoplastic activity in vitro and in vivo. Acta Oncologica 28, 213-217. (Pubitemid 19159628)
46. Vonlaufen, N., Guetg, N., Naguleswaran, A., Müller, N., Björkman, C., Schares, G., von Blumroeder, D., Ellis, J. and Hemphill, A. (2004). In vitro induction of Neospora caninum bradyzoites in vero cells reveals differential antigen expression, localization, and host-cell recognition of tachyzoites and bradyzoites. Infection and Immunity 72, 576-583. (Pubitemid 38018219)
47. Vonlaufen, N., Müller, N., Keller, N., Naguleswaran, A., Bohne,W., McAllister, M. M., Björkman, C., Müller, E., Caldelari, R. and Hemphill, A. (2002). Exogenous nitric oxide triggers Neospora caninum tachyzoite-to-bradyzoite stage conversion in murine epidermal keratinocyte cell cultures. International Journal for Parasitology 32, 1253-1265. (Pubitemid 35232177)
48. Walochnik, J., Duchene, M., Seifert, K., Obwaller, A., Hottkowitz, T., Wiedermann, G., Eibl, H. and Aspöck, H. (2002). Cytotoxic activities of alkylphosphocholines against clinical isolates of Acanthamoeba spp. Antimicrobial Agents and Chemotherapy 46, 695-701. (Pubitemid 34157653)
49. Youn, H. J., Lakritz, J., Rottinghaus, G. E., Seo, H. S., Kim, D. Y., Cho, M.H. and Marsh, A. E. (2004). Anti-protozoal efficacy of high performance liquid chromatography fractions of Torilis japonica and Sophora flavescens extracts on Neospora caninum and Toxoplasma gondii. Veterinary Parasitology 125, 409-414. (Pubitemid 39346411)